28
October

08:00 AM BST

Medicinal Chemistry

Name: Medicinal Chemistry Strategy Meeting Europe 2026
Start: 2025-10-16T08:00
End: 2025-10-16T18:00
Location: Crowne Plaza, London Docklands

&

Drug Discovery Biology & Bioinformatics

Strategy Meeting Europe 2026

Strengthening the Synergy Between Medicinal Chemistry, Drug Discovery Biology and Bioinformatics To Drive Informed Decision-making Across The Drug Discovery Continuum

Crowne Plaza London Docklands

Our Event Starts In

–
days

–
hours

–
minutes

–
seconds

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Drug Discovery Biology & Medicinal Chemistry Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Medicinal Chemistry professionals from across Europe, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Our Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.

Alan Palmer

Chief Executive Officer Elixa MediScience

Ben Thomas

Senior Vice President: External Innovation and Operations Oxford BioTherapeutics

Dominic Smethurst

Chief Medical Officer Corbus Therapeutics

Matthew Fyfe

Chief Scientific Officer Outrun Tx

Markus Queisser

Scientific Director GSK

Simon Westbrook

CSO and Founder Levicept Ltd

Steve Andrews

Head of Chemistry and Operations, ALBORADA Drug Discovery Institute University of Cambridge

Steven Zimmer

CEO Dark Matter Therapeutics

Tom Diethe

Executive Director, Head of the Centre for Artificial Intelligence AstraZeneca

First name	Last name	Job title	Company name	Photo URL	Bio Position
Alan	Palmer	Chief Executive Officer	Elixa MediScience	https://proventainternational.com/wp-content/uploads/2025/09/Alan-parmer.png
Ben	Thomas	Senior Vice President: External Innovation and Operations	Oxford BioTherapeutics	https://proventainternational.com/wp-content/uploads/2026/06/Ben-Thomas.jpg
Dominic	Smethurst	Chief Medical Officer	Corbus Therapeutics	https://proventainternational.com/wp-content/uploads/2026/06/Dominic-Smethurst.jpg
Matthew	Fyfe	Chief Scientific Officer	Outrun Tx	https://proventainternational.com/wp-content/uploads/2020/04/Matthew-Fyfe-1.jpg
Markus	Queisser	Scientific Director	GSK	https://proventainternational.com/wp-content/uploads/2024/07/Markus-Queisser.jpg
Simon	Westbrook	CSO and Founder	Levicept Ltd	https://proventainternational.com/wp-content/uploads/2026/06/Simon-Westbrook.jpg
Steve	Andrews	Head of Chemistry and Operations, ALBORADA Drug Discovery Institute	University of Cambridge	https://proventainternational.com/wp-content/uploads/2026/06/Steve-Andrews.jpg
Steven	Zimmer	CEO	Dark Matter Therapeutics	https://proventainternational.com/wp-content/uploads/2020/03/Steven-Zimmer.jpg	Topic: Stratgic partnership of AI startup and Pharma (9:00am – 10:00am)
Tom	Diethe	Executive Director, Head of the Centre for Artificial Intelligence	AstraZeneca	https://proventainternational.com/wp-content/uploads/2026/06/Tom-Diethe.jpg

Alan Palmer, Ben Thomas, Dominic Smethurst, Matthew Fyfe, Markus Queisser, Simon Westbrook, Steve Andrews, Steven Zimmer, Tom Diethe

Our Past Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.

Alessandro Mazzacani

Director of Chemistry and IP Sitryx

Chris Luckhurst

Head of Chemistry ThirtyFiveBio

Daniel Gironés

Managing Director Sapiens Natura Pharma

Elisabetta Chiarparin

Former SVP, Head of Discovery & Development Technologies Merck

Guido Koch

Chief Executive Officer Amphilix

Guido Koch is a board member of SynpleChem and co-founder and CEO of <a href="https://www.amphilix.com/">Amphilx</a>. From 2018 to 2020, Guido was the COO of Topadur Pharma and before a Director in Global Discovery Chemistry at Novartis.
During his career in drug discovery and development, Guido has lead projects in different phases from target identification to early clinical stage including multiple kinase inhibitors. Highlights from >20 years of experience in pharmaceutical industry include significant contributions to one marketed product and 8 clinical candidates.
Guido has built a strong network with academia and the CRO community, which allows him to support research programs by external knowledge, new technology and resources. His research has culminated in >45 scientific publications and 10 patent applications.
Educated at ETH Zürich, he received his Diploma in Chemistry and Biochemistry in 1991, followed from a PhD from the University of Basel. After a postdoc at Caltech, he joined Novartis in 1997.

Ismail Ijjaali, Ph.D

Director, EMEAI Field Application Scientist Team Revvity Signals

Markus Queisser

Scientific Director GSK

Matthew Fyfe

Chief Scientific Officer Outrun Tx

May Rezai

Chief Operations Officer MirZyme Therapeutics

Nicolas Triballeau, Ph.D

Director, Drug Discovery Chemistry Revvity Signals

Stephen Harrison

Former CSO Nucleome Therapeutics

Steven Zimmer

CEO Dark Matter Therapeutics

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

09:00 - 10:00

Roundtable Tracks

AI/ML/Data Science
AI-Driven Design for Challenging Modalities & “Hard” Targets (e.g. Kinases, Allosteric Sites, Undruggables, Protein Degraders)

Chemical Biology, Targeted Protein Degradation & Undruggables
The Future of Undruggables: Integrating AI, Chemoproteomics, and Targeted Degradation

Target Identification To Proof Of Concept
Structure Enabled Design Transforming Early Discovery and Fast Tracking Lead Optimization

Integrated Drug Discovery
End-to-End Integrated Drug Discovery Pipelines from Data to Molecule

Investment & Strategic Partnerships In Drug Discovery
Enabling Biotech and Virtual Pharma — Outsourced R&D, Manufacturing, and Testing for Lean, High‑Velocity Drug Developers

11:10 - 12:10

Roundtable Tracks

AI/ML/Data Science
Harnessing AI and Data Science for Advances in Medicinal Chemistry, Drug Discovery Biology, and Bioinformatics

Revvity Signals

Chemical Biology, Targeted Protein Degradation & Undruggables
The Next Generation of Degrader Architectures Reshaping Undruggable Targets in 2026 - Beyond PROTACs 2.0

Sponsor

Target Identification To Proof Of Concept
Streamlining Chemistry, Biology, and Analytics: Integrated Platforms for Faster Hit-to‑Lead and Lead-to‑Preclinical Transitions

Sponsor

Integrated Drug Discovery
Holistic Risk Management: From Early‑Stage Discovery to Preclinical Development — Minimizing Failures through Integrated Workflows

Revvity Signals

Investment & Strategic Partnerships In Drug Discovery
The Role of Machine Learning and AI-Powered Data Platforms in Shaping Future Investment Decisions and Portfolio Strategy

Sponsor

12:15 - 13:15

Roundtable Tracks

AI/ML/Data Science
Data Science and Artificial Intelligence for Next-Generation Therapeutics

Chemical Biology, Targeted Protein Degradation & Undruggables
Hit-to-Lead Strategies for PROTACs, Molecular Glues & Targeted Protein Degradation

Target Identification To Proof Of Concept
From Target Identification to Proof of Concept: Integrating Translational Biology, DMPK, and Quantitative Pharmacology for Successful Drug Discovery.

Integrated Drug Discovery
From Target to Tablet: End‑to‑End Small Molecule Drug Development via Integrated Discovery, DMPK, and Manufacture

Investment & Strategic Partnerships In Drug Discovery
Partnering to Shorten the Discovery and Development Timeline

14:40 - 15:10

Revvity Signals

15:10 - 16:10

Roundtable Tracks

AI/ML/Data Science
AI-Enabled Design for Complex Biology: CNS Targets, RNA Therapeutics, Multimodal / Multi-target Drugs, Personalized Medicine

Chemical Biology, Targeted Protein Degradation & Undruggables
Integrative Data Science Framework for PROTAC Target Discovery and Design

Target Identification To Proof Of Concept
The New Frontier of Hit Identification: High-Dimension Screens, DNA-Encoded Libraries & Virtual Exploration

Integrated Drug Discovery
Multi-Agent AI Systems for Autonomous Drug Discovery

Investment & Strategic Partnerships In Drug Discovery
Partnering Science and Strategy: Translating Integrated Discovery Pipelines into Value for Investors, Collaborators, and Patients

Press play to hear what your colleagues had to say...

Hotel & Venue

Crowne Plaza London Docklands

Our hotel is a haven from the hustle & bustle of London life - you’ll find peace & tranquility in modern surroundings. We’re close to The O2 Arena, ExCeL Exhibition Centre & Canary Wharf.

Hotel Details Map & Directions Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Europe

Medicinal Chemistry Strategy Meeting Europe 2024

&

Strategy Meeting Europe 2026

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Crowne Plaza London Docklands

Fresh Drug Discovery Biology & Medicinal Chemistry Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Our Facilitators

Alan Palmer

Ben Thomas

Dominic Smethurst

Matthew Fyfe

Markus Queisser

Simon Westbrook

Steve Andrews

Steven Zimmer

Tom Diethe

Our Past Facilitators

Alessandro Mazzacani

Chris Luckhurst

Daniel Gironés

Elisabetta Chiarparin

Guido Koch

Ismail Ijjaali, Ph.D

Markus Queisser

Matthew Fyfe

May Rezai

Nicolas Triballeau, Ph.D

Stephen Harrison

Steven Zimmer

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

Registration & Welcoming

Opening Keynote Presentation

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Refreshment Break

Networking/1-1 Meetings

Networking/1-1 Meetings

Networking/1-1 Meetings

Roundtable ( Solutions )

Roundtable Tracks

Revvity Signals

Sponsor

Sponsor

Revvity Signals

Sponsor

Rountable Discussion ( Pharma/Biotech )

Roundtable Tracks

Networking Lunch

Networking/1-1 Meetings

Networking/1-1 Meetings

Afternoon Keynote Presentation

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Afternoon Refreshment Break

Panel Discussion

Drinks & Canapes Reception

See the full agenda and facilitator line-up

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

Senior Decision Makers

Personalised Agendas

Private and Intimate Networking

Our 2026 Sponsors

Lead Sponsor

Our Past Sponsors

Lead Sponsor

Crowne Plaza London Docklands